Jefferies European Stock Sweep: Buy on Siemens Energy and Fresenius, Underperform on K+S

The Quick Take

• Jefferies issued a sweep of European stock ratings: Buy on Fresenius (€55 PT) and Siemens Energy (€215), Hold on Bayer (€46) and Akzo Nobel (€55), Underperform on K+S (€10.50).
• Siemens Energy's Buy rating was driven by US heatwave boosting grid operator PJM revenues, signaling AI-driven power infrastructure demand is reaching US utility earnings.
• Bayer's Hold reflects positive Supreme Court ruling on glyphosate litigation, capping downside but insufficient for upgrade without earnings visibility.

Jefferies issued a cross-sector European equity rating update covering five companies on Monday. The most bullish calls were on Fresenius (Buy, €55 price target) and Siemens Energy (Buy, €215). The Siemens Energy upgrade rationale is notable: Jefferies analyst cited the early July US heatwave boosting revenues for PJM, the northeastern US grid operator, as evidence that AI-driven power infrastructure demand is reaching utility and energy grid earnings. This connects European energy infrastructure stocks directly to the US AI buildout demand cycle, providing a transatlantic demand read-through.

Bayer received a Hold with a €46 price target following a positive US Supreme Court ruling on glyphosate litigation — the court ruling reduces the overhang from the Roundup lawsuits that have depressed Bayer's share price for years. Jefferies considers the ruling positive but insufficient for an upgrade without clearer earnings visibility on the agricultural and pharmaceutical segments. Akzo Nobel (Hold, €55) had its rating maintained amid an ongoing takeover offer, which Jefferies analyst Marcus Dunford-Castro referenced as context. K+S received an Underperform with a reduced price target of €10.50 from €11.50, ahead of Q2 earnings scheduled for August 12.

Watch the K+S Q2 earnings on August 12 — the downgrade and price target cut signals Jefferies expects a weak result, and the stock's reaction will test whether the negative thesis is correctly priced. For Siemens Energy, US utility summer earnings season will provide the first real data point on whether grid operator revenue uplift from AI-driven power demand is as significant as the Jefferies analysis suggests. The macro variable for Bayer is the US litigation pipeline: additional Supreme Court or appellate rulings on glyphosate would move the stock more than earnings guidance at this stage.

Synthesized from 5 sources.